17 July 2013
Medical Startup Neural Analytics closed first seed round on $250K. The company, founded by graduates of MBA UCLA Anderson School of Management, created algorithm based on ten years investigation, conducted by Medical Center of UCLA University, use of which allows to the accuracy 92% measure increased intracranial pressure by noninvasive method.
Finances have been provided by representatives of the Funds Detonate Ventures and Venture Angels, and also private investor – doctor from Hong-Kong. Leading investor became a partner of SKOLKOVO Investors Club – the company Bears Investment Group.
Ultrasound device measures speed of cerebral blood flow, and, placing it on comparative data of conducted medicine investigations, during several seconds can define whether a human is addicted to increased intracranial pressure and needs additional therapy.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024